May Hua1, Damon C Scales, Zara Cooper, Ruxandra Pinto, Vivek Moitra, Hannah Wunsch. 1. From the Department of Anesthesiology, Columbia University College of Physicians and Surgeons (M.H., V.M., H.W.); Department of Critical Care Medicine, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada (D.C.S., H.W.); Department of Medicine, Interdepartmental Division of Critical Care (D.C.S.), Department of Anesthesia (H.W.), and Interdisciplinary Department of Critical Care Medicine (H.W.), University of Toronto, Toronto, Ontario, Canada; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Z.C.); and Department of Critical Care Medicine, Sunnybrook Research Institute, Toronto, Ontario, Canada (R.P., H.W.).
Abstract
BACKGROUND: Recent reports have raised concerns that public reporting of 30-day mortality after cardiac surgery may delay decisions to withdraw life-sustaining therapies for some patients. The authors sought to examine whether timing of mortality after coronary artery bypass graft surgery significantly increases after day 30 in Massachusetts, a state that reports 30-day mortality. The authors used New York as a comparator state, which reports combined 30-day and all in-hospital mortality, irrespective of time since surgery. METHODS: The authors conducted a retrospective cohort study of patients who underwent coronary artery bypass graft surgery in hospitals in Massachusetts and New York between 2008 and 2013. The authors calculated the empiric daily hazard of in-hospital death without censoring on hospital discharge, and they used joinpoint regression to identify significant changes in the daily hazard over time. RESULTS: In Massachusetts and New York, 24,864 and 63,323 patients underwent coronary artery bypass graft surgery, respectively. In-hospital mortality was low, with 524 deaths (2.1%) in Massachusetts and 1,398 (2.2%) in New York. Joinpoint regression did not identify a change in the daily hazard of in-hospital death at day 30 or 31 in either state; significant joinpoints were identified on day 10 (95% CI, 7 to 15) for Massachusetts and days 2 (95% CI, 2 to 3) and 12 (95% CI, 8 to 15) for New York. CONCLUSIONS: In Massachusetts, a state with a long history of publicly reporting cardiac surgery outcomes at day 30, the authors found no evidence of increased mortality occurring immediately after day 30 for patients who underwent coronary artery bypass graft surgery. These findings suggest that delays in withdrawal of life-sustaining therapy do not routinely occur as an unintended consequence of this type of public reporting.
BACKGROUND: Recent reports have raised concerns that public reporting of 30-day mortality after cardiac surgery may delay decisions to withdraw life-sustaining therapies for some patients. The authors sought to examine whether timing of mortality after coronary artery bypass graft surgery significantly increases after day 30 in Massachusetts, a state that reports 30-day mortality. The authors used New York as a comparator state, which reports combined 30-day and all in-hospital mortality, irrespective of time since surgery. METHODS: The authors conducted a retrospective cohort study of patients who underwent coronary artery bypass graft surgery in hospitals in Massachusetts and New York between 2008 and 2013. The authors calculated the empiric daily hazard of in-hospital death without censoring on hospital discharge, and they used joinpoint regression to identify significant changes in the daily hazard over time. RESULTS: In Massachusetts and New York, 24,864 and 63,323 patients underwent coronary artery bypass graft surgery, respectively. In-hospital mortality was low, with 524 deaths (2.1%) in Massachusetts and 1,398 (2.2%) in New York. Joinpoint regression did not identify a change in the daily hazard of in-hospital death at day 30 or 31 in either state; significant joinpoints were identified on day 10 (95% CI, 7 to 15) for Massachusetts and days 2 (95% CI, 2 to 3) and 12 (95% CI, 8 to 15) for New York. CONCLUSIONS: In Massachusetts, a state with a long history of publicly reporting cardiac surgery outcomes at day 30, the authors found no evidence of increased mortality occurring immediately after day 30 for patients who underwent coronary artery bypass graft surgery. These findings suggest that delays in withdrawal of life-sustaining therapy do not routinely occur as an unintended consequence of this type of public reporting.
Authors: Denise Riedel Lewis; Huann-Sheng Chen; Myles G Cockburn; Xiao-Cheng Wu; Antoinette M Stroup; Douglas N Midthune; Zhaohui Zou; Martin F Krapcho; Daniel G Miller; Eric J Feuer Journal: Cancer Date: 2017-02-14 Impact factor: 6.860
Authors: Terrah J Paul Olson; Karen J Brasel; Andrew J Redmann; G Caleb Alexander; Margaret L Schwarze Journal: JAMA Surg Date: 2013-01 Impact factor: 14.766
Authors: Eduard E Vasilevskis; Michael W Kuzniewicz; Mitzi L Dean; Ted Clay; Eric Vittinghoff; Deborah J Rennie; R Adams Dudley Journal: Med Care Date: 2009-07 Impact factor: 2.983
Authors: Ahmedin Jemal; Elizabeth M Ward; Christopher J Johnson; Kathleen A Cronin; Jiemin Ma; Blythe Ryerson; Angela Mariotto; Andrew J Lake; Reda Wilson; Recinda L Sherman; Robert N Anderson; S Jane Henley; Betsy A Kohler; Lynne Penberthy; Eric J Feuer; Hannah K Weir Journal: J Natl Cancer Inst Date: 2017-09-01 Impact factor: 13.506
Authors: Robert E Freundlich; Sara E Nelson; Yuxuan Qiu; Jesse M Ehrenfeld; Warren S Sandberg; Jonathan P Wanderer Journal: J Clin Monit Comput Date: 2018-12-08 Impact factor: 2.502
Authors: Yixian Qiu; Robert E Freundlich; Sara Nelson; Catherine Clark; Jesse M Ehrenfeld; Jonathan P Wanderer Journal: J Med Syst Date: 2019-04-25 Impact factor: 4.460
Authors: Patrick G Chan; Laura Seese; Edgar Aranda-Michel; Ibrahim Sultan; Thomas G Gleason; Yisi Wang; Floyd Thoma; Arman Kilic Journal: J Thorac Dis Date: 2021-10 Impact factor: 2.895